Managing Mild Cognitive Impairment Resulting From Chemotherapy

Chemobrain is a common term used to describe thinking and memory problems that can occur during and/or after cancer treatment. Chemobrain can also be called chemo fog, chemotherapy-related cognitive impairment, or cognitive dysfunction.

These impairments although mild, can have a significant impact on function in the home, community, and work settings. This presentation will discuss ways to optimize day to day memory, attention, word-retrieval, and organization skills through the use of strategies/tools. These strategies have the potential to reduce the negative impact of chemotherapy-related cognitive impairment and improve safety and independence.

Open to client and caregivers.  Free program with optional donations accepted at registration.  This program will meet on zoom. 

Mary Ann Williams-Butler, MA, CCC-SLP, CBIS

Speech-Language Pathologist, Certified Brain Injury Specialist

Emerson Health

Mary Ann Williams-Butler has more than 35 years of experience as a speech/language pathologist and is a certified brain injury specialist through the Brain Injury Association of America. She has held adjunct faculty appointments in the communication disorders department at Worcester State University, served as a subject matter expert in pediatric TBI for the American Speech/Language Hearing Association’s practice portal, and has presented nationally and internationally on the following topics: dysphagia, memory deficits, cognitive pragmatic deficits, and traumatic brain injury. In 2019, she published the research article “Concussion Practice Patterns Among Speech-Language Pathologists”. Ms. Williams-Butler provides evaluation and treatment to address swallowing, speech, and cognitive difficulties related to cancer or the side effects of cancer treatment such as radiation, chemotherapy, or surgery.